Menu

• Ask a Health Expert about APPLICATION SITE DISCOLOURATION
• Post Your Side Effect related to APPLICATION SITE DISCOLOURATION
• APPLICATION SITE DISCOLOURATION and FDA Warnings
• APPLICATION SITE DISCOLOURATION in Patients Wiki
• Report APPLICATION SITE DISCOLOURATION in Drug Side Effect Survey

APPLICATION SITE DISCOLOURATION side effect

What is APPLICATION SITE DISCOLOURATION ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Desenex Side Effects Report #5616271-X
Physician from UNITED STATES reported DESENEX problem on Jan 29, 2008. Male patient, 54 years of age, weighting 175.0 lb, was diagnosed with tinea pedis and was treated with DESENEX. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site erythema, application site vesicles, hyperhidrosis, hypersensitivity, oedema peripheral, . DESENEX dosage: unknown. During the same period patient was treated with NEXIUM. Patient recovered.

Target Side Effects Report #5625926-2
TARGET BRAND COLD HOT CREAM METHYL SALICYLATE problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 12, 2008. Female patient, weighting 158.0 lb, was diagnosed with carpal tunnel syndrome and was treated with TARGET BRAND COLD HOT CREAM METHYL SALICYLATE. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site irritation, . TARGET BRAND COLD HOT CREAM METHYL SALICYLATE dosage: unknown. Patient recovered.

Lamisil Side Effects Report #5637327-1
Consumer or non-health professional from UNITED STATES reported LAMISIL AT problem on Feb 07, 2008. Female patient, 62 years of age, weighting 108.9 lb, was diagnosed with fungal infection and was treated with LAMISIL AT. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site irritation, . LAMISIL AT dosage: unknown. During the same period patient was treated with ATENOLOL, HYDROCHLOROTHIAZIDE, CLONIDINE. Patient recovered.

Catapres Side Effects Report #5538063-2
CATAPRES problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 12, 2007. Female patient, 85 years of age, was diagnosed with hypertension and was treated with CATAPRES. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site erythema, application site pruritus, application site vesicles, fatigue, . CATAPRES dosage: unknown. Patient recovered.


Emsam Side Effects Report #5546099-0
Consumer or non-health professional from UNITED STATES reported EMSAM problem on Oct 09, 2007. Male patient, 34 years of age, weighting 160.9 lb, was diagnosed with depression and was treated with EMSAM. After drug was administered, patient experienced the following problems/side effects: application site discolouration, . EMSAM dosage: unknown. During the same period patient was treated with KLONOPIN. Patient recovered.

Nicotine Side Effects Report #5552642-8
NICOTINE problem was reported by a Physician from UNITED STATES on Nov 21, 2007. Male patient, 46 years of age, was treated with NICOTINE. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site erythema, application site excoriation, application site reaction, application site scar, open wound, scab, skin injury, . NICOTINE dosage: 21 MG, QD, TRANSDERMAL. Patient recovered.

Fentanyl Side Effects Report #5570284-5
Health Professional from UNITED STATES reported FENTANYL TRANSDERMAL SYSTEM problem on Dec 19, 2007. Male patient, 14 years of age, weighting 77.16 lb, was diagnosed with pain and was treated with FENTANYL TRANSDERMAL SYSTEM. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site pruritus, . FENTANYL TRANSDERMAL SYSTEM dosage: unknown. Patient recovered.

Catapres Side Effects Report #5517643-4
CATAPRES problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 08, 2007. Female patient, 46 years of age, was diagnosed with hypertension and was treated with CATAPRES. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site rash, application site reaction, application site swelling, . CATAPRES dosage: unknown. During the same period patient was treated with INSULIN, COZAAR, FOSAMAX, LIPITOR, ESTRATEST, ASPIRIN, CALCIUM. Patient recovered.

Fentanyl Side Effects Report #5473328-4
Consumer or non-health professional from UNITED STATES reported FENTANYL TRANSDERMAL SYSTEM problem on Sept 20, 2007. Male patient, weighting 175.0 lb, was diagnosed with spinal fracture, gastrooesophageal reflux disease, blood pressure, pain and was treated with FENTANYL TRANSDERMAL SYSTEM. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site pruritus, dementia, . FENTANYL TRANSDERMAL SYSTEM dosage: unknown. During the same period patient was treated with PROTONIX, HYDROCHLOROTHIAZIDE, LISINOPRIL, TYLENOL ARTHRITIS. Patient recovered.


Ventolin Side Effects Report #5479688-2
VENTOLIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 02, 2007. Female patient, child 10 years of age, weighting 87.08 lb, was treated with VENTOLIN. After drug was administered, patient experienced the following problems/side effects: application site discolouration, burning sensation, thermal burn, . VENTOLIN dosage: unknown. Patient recovered.

Desenex Side Effects Report #5492696-0
Consumer or non-health professional from UNITED STATES reported DESENEX PRESCRIPTIONS STRENGTH ANTIFPOWER problem on Oct 10, 2007. Male patient, 54 years of age, weighting 175.0 lb, was diagnosed with tinea pedis and was treated with DESENEX PRESCRIPTIONS STRENGTH ANTIFPOWER. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site erythema, application site vesicles, hyperhidrosis, oedema peripheral, . DESENEX PRESCRIPTIONS STRENGTH ANTIFPOWER dosage: unknown. During the same period patient was treated with NEXIUM. Patient recovered.

Catapres Side Effects Report #5499755-7
CATAPRES problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 08, 2007. Female patient, 46 years of age, was diagnosed with hypertension and was treated with CATAPRES. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site rash, . CATAPRES dosage: unknown. During the same period patient was treated with INSULIN PUMP, COZAAR, FOSAMAX, LIPITOR, ESTRATEST, ASPIRIN, CALCIUM. Patient recovered.

Actiq Side Effects Report #5451977-7
Pharmacist from FRANCE reported ACTIQ problem on Aug 29, 2007. Male patient, 60 years of age, was diagnosed with cancer pain and was treated with ACTIQ. After drug was administered, patient experienced the following problems/side effects: application site discolouration, necrosis, tongue disorder, . ACTIQ dosage: unknown. During the same period patient was treated with TOPALGIC, ACETAMINOPHEN, OGAST. Patient died.

Abreva Side Effects Report #5461371-0
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 27, 2006. Male patient, 37 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site exfoliation, application site irritation, hypersensitivity, . ABREVA dosage: unknown. Patient recovered.


Abreva Side Effects Report #5461632-5
Consumer or non-health professional from UNITED STATES reported ABREVA problem on Nov 16, 2006. Male patient, 49 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site erythema, application site rash, application site scar, oral herpes, . ABREVA dosage: unknown. Patient recovered.

Abreva Side Effects Report #5461633-7
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 17, 2006. Female patient, 30 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site discolouration, . ABREVA dosage: unknown. Patient recovered.

Abreva Side Effects Report #5461685-4
Consumer or non-health professional from UNITED STATES reported ABREVA problem on Nov 30, 2006. Female patient, 47 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site reaction, oral herpes, . ABREVA dosage: unknown. Patient recovered.

Abreva Side Effects Report #5462250-5
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on June 05, 2007. Female patient, 43 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site discolouration, . ABREVA dosage: unknown. Patient recovered.

Abreva Side Effects Report #5462607-2
Consumer or non-health professional from UNITED STATES reported ABREVA problem on Feb 08, 2007. Female patient, 40 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site discolouration, . ABREVA dosage: unknown. Patient recovered.


Abreva Side Effects Report #5462645-X
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 14, 2007. Female patient, 28 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site scab, . ABREVA dosage: unknown. Patient recovered.

Abreva Side Effects Report #5462701-6
Consumer or non-health professional from UNITED STATES reported ABREVA problem on Aug 08, 2007. Female patient, 25 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site papules, . ABREVA dosage: unknown. Patient recovered.

Abreva Side Effects Report #5462851-4
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 27, 2007. Female patient, 41 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site irritation, application site scar, hypersensitivity, hypoaesthesia oral, oral herpes, . ABREVA dosage: unknown. Patient recovered.

Bengay Side Effects Report #5471013-6
Consumer or non-health professional from UNITED STATES reported BENGAY ULTRA STRENGTH PATCH problem on Sept 17, 2007. Female patient, 36 years of age, was diagnosed with back pain and was treated with BENGAY ULTRA STRENGTH PATCH. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site erythema, application site irritation, application site pruritus, . BENGAY ULTRA STRENGTH PATCH dosage: unknown. Patient recovered.

Nicotine Side Effects Report #5409868-3
NICOTINE problem was reported by a Consumer or non-health professional from JAPAN on July 24, 2007. Male patient was treated with NICOTINE. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site erythema, application site vesicles, insomnia, lip swelling, urticaria, . NICOTINE dosage: 21 MG, QD, TRANSDERMAL, 14 MG, QD, TRANSDERMAL. Patient recovered.

Fentanyl Side Effects Report #5416425-1
Consumer or non-health professional from UNITED STATES reported FENTANYL TRANSDERMAL SYSTEM problem on Aug 06, 2007. Male patient, weighting 175.0 lb, was diagnosed with spinal fracture, gastrooesophageal reflux disease, blood pressure, pain and was treated with FENTANYL TRANSDERMAL SYSTEM. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site pruritus, dementia, . FENTANYL TRANSDERMAL SYSTEM dosage: unknown. During the same period patient was treated with PROTONIX, HYDROCHLOROTHIAZIDE, LISINOPRIL, TYLENOL ARTHRITIS. Patient recovered.

Ortho Side Effects Report #5406327-9
ORTHO EVRA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 24, 2006. Female patient, 22 years of age, was diagnosed with contraception and was treated with ORTHO EVRA. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site erythema, application site pain, application site pruritus, application site swelling, . ORTHO EVRA dosage: unknown. Patient recovered.

Ortho Side Effects Report #5406327-9
Consumer or non-health professional from UNITED STATES reported ORTHO EVRA problem on Oct 24, 2006. Female patient, 22 years of age, was diagnosed with contraception and was treated with ORTHO EVRA. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site erythema, application site pain, application site pruritus, application site swelling, . ORTHO EVRA dosage: unknown. Patient recovered.

Neupro Side Effects Report #5764384-4
NEUPRO problem was reported by a Consumer or non-health professional from UNITED STATES on May 19, 2008. Male patient, 65 years of age, weighting 160.0 lb, was diagnosed with parkinson's disease and was treated with NEUPRO. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site irritation, application site pruritus, application site swelling, . NEUPRO dosage: 4MG/24H, 1 IN 1 D, TRANSDERMAL; 2MG/24H,1 IN D, TRANSDERMAL. During the same period patient was treated with STALEVO, AMANTADINE, AZILECT. Patient recovered.

Neupro Side Effects Report #5774825-4
Health Professional from UNITED STATES reported NEUPRO problem on June 16, 2008. Female patient, weighting 138.0 lb, was diagnosed with parkinson's disease and was treated with NEUPRO. After drug was administered, patient experienced the following problems/side effects: application site discolouration, . NEUPRO dosage: 6 MG Q24HOURS TRANSDERMAL. Patient recovered.

Equate Side Effects Report #5793273-4
EQUATE problem was reported by a Consumer or non-health professional from UNITED STATES on June 26, 2008. Male patient, 59 years of age, weighting 205.0 lb, was diagnosed with sterilisation and was treated with EQUATE. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site excoriation, application site irritation, application site pain, onychomadesis, wound, . EQUATE dosage: unknown. Patient recovered.

Bengay Side Effects Report #5731314-0
Consumer or non-health professional from UNITED STATES reported BENGAY ULTRA STRENGTH PATCH problem on Apr 22, 2008. Male patient, 23 years of age, weighting 235.0 lb, was diagnosed with neck pain and was treated with BENGAY ULTRA STRENGTH PATCH. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site irritation, application site vesicles, . BENGAY ULTRA STRENGTH PATCH dosage: unknown. Patient recovered.

Duragesic Side Effects Report #5739873-9
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on May 05, 2008. Female patient, weighting 188.0 lb, was diagnosed with back pain, cardiovascular event prophylaxis, thyroid disorder, breakthrough pain, anxiety and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site irritation, application site vesicles, arthritis, back pain, blood iron decreased, constipation, depression, dry skin, . DURAGESIC dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM, EPIDURAL, ASPIRIN, SYNTHROID, VICODIN, AMITRIPTYLINE, CLONAZEPAM. Patient recovered.

Neupro Side Effects Report #5676791-9
Consumer or non-health professional from UNITED STATES reported NEUPRO problem on Feb 05, 2008. Male patient, 71 years of age, was treated with NEUPRO. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site reaction, . NEUPRO dosage: 6MG/24H, 1 IN 1 D, TRANSDERMAL. Patient recovered.

Climara Side Effects Report #5698464-9
CLIMARA problem was reported by a Consumer or non-health professional from UNITED STATES on May 25, 2006. Female patient, 48 years of age, weighting 163.1 lb, was treated with CLIMARA. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site excoriation, application site rash, . CLIMARA dosage: unknown. Patient recovered.

Climara Side Effects Report #5698607-7
Consumer or non-health professional from UNITED STATES reported CLIMARA problem on Nov 22, 2006. Female patient, 50 years of age, weighting 158.7 lb, was diagnosed with menopausal symptoms and was treated with CLIMARA. After drug was administered, patient experienced the following problems/side effects: application site discolouration, . CLIMARA dosage: unknown. During the same period patient was treated with ATENOLOL. Patient recovered.

Climara Side Effects Report #5698630-2
CLIMARA problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 27, 2006. Female patient, 60 years of age, weighting 130.1 lb, was treated with CLIMARA. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site pruritus, blood blister, . CLIMARA dosage: unknown. During the same period patient was treated with EYE DROPS, CHOLESTEROL. Patient recovered.

Duragesic Side Effects Report #5376864-4
Physician from UNITED STATES reported DURAGESIC problem on June 28, 2007. Female patient, weighting 112.0 lb, was diagnosed with pain and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site discolouration, . DURAGESIC dosage: 100MG Q 72 HR DERMAL. During the same period patient was treated with TOPAMAX, CYMBALTA, FLEXERIL, PROVIGIL, AVINZA. Patient recovered.

Duragesic Side Effects Report #5376874-7
DURAGESIC problem was reported by a Physician from UNITED STATES on June 28, 2007. Male patient, weighting 233.0 lb, was diagnosed with pain and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site discolouration, . DURAGESIC dosage: 25MG Q 72 HR DERMAL. During the same period patient was treated with OXYCONTIN, BEXTRA. Patient recovered.

Amiodarone Side Effects Report #5328151-8
Consumer or non-health professional from UNITED KINGDOM reported AMIODARONE problem on May 01, 2007. Male patient, 61 years of age, was diagnosed with ventricular fibrillation and was treated with AMIODARONE. After drug was administered, patient experienced the following problems/side effects: application site discolouration, blister, infusion site extravasation, oedema peripheral, skin necrosis, . AMIODARONE dosage: 900 MG IV. Patient recovered.

Bactroban Side Effects Report #5334234-9
BACTROBAN problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 24, 2007. Female patient, 93 years of age, was diagnosed with skin lesion and was treated with BACTROBAN. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site erythema, application site warmth, . BACTROBAN dosage: unknown. During the same period patient was treated with LIPITOR, TOPROL, SYNTHROID, ASPIRIN, ASCORBIC ACID. Patient recovered.

Nicotine Side Effects Report #5297668-7
Physician from JAPAN reported NICOTINE problem on Mar 28, 2007. Female patient, 45 years of age, was treated with NICOTINE. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site erosion, application site erythema, application site pruritus, application site scar, application site vesicles, dermatitis contact, . NICOTINE dosage: unknown. Patient recovered.

Oxytrol Side Effects Report #5277216-8
OXYTROL problem was reported by a Pharmacist from UNITED STATES on Mar 22, 2007. Female patient, 59 years of age, weighting 205.0 lb, was diagnosed with urinary incontinence and was treated with OXYTROL. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site dryness, . OXYTROL dosage: unknown. Patient recovered.

Duragesic Side Effects Report #5281345-2
Health Professional from UNITED KINGDOM reported DURAGESIC problem on Mar 23, 2007. Male patient, 62 years of age, weighting 154.0 lb, was diagnosed with analgesic effect and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site discolouration, . DURAGESIC dosage: unknown. During the same period patient was treated with AMLODIPINE, ASPIRIN, ATENOLOL, ATORVASTATIN CALCIUM, CLOPIDOGREL, LISINOPRIL, MIRTAZAPINE. Patient recovered.

Bengay Side Effects Report #5495403-0
BENGAY ULTRA STRENGTH PATCH problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 17, 2007. Female patient, 36 years of age, was diagnosed with back pain and was treated with BENGAY ULTRA STRENGTH PATCH. After drug was administered, patient experienced the following problems/side effects: application site burn, application site discolouration, application site irritation, application site pruritus, . BENGAY ULTRA STRENGTH PATCH dosage: unknown. Patient recovered.

Aldara Side Effects Report #5500223-4
Consumer or non-health professional from UNITED STATES reported ALDARA problem on Oct 22, 2007. Male patient, 70 years of age, was treated with ALDARA. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site erythema, application site irritation, application site scab, hypercoagulation, overdose, skin discolouration, . ALDARA dosage: unknown. Patient was hospitalized. Patient recovered.

Abreva Side Effects Report #5462636-9
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 14, 2007. Female patient, 81 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site bleeding, application site discolouration, application site dryness, application site pain, application site reaction, . ABREVA dosage: unknown. Patient recovered.

Duragesic Side Effects Report #5380862-4
Consumer or non-health professional from UNITED STATES reported DURAGESIC problem on June 26, 2007. Female patient, 40 years of age, weighting 210.0 lb, was diagnosed with pain and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site discolouration, homicide, overdose, . DURAGESIC dosage: unknown. During the same period patient was treated with OXYCONTIN. Patient died on 05/01/2004.

Duragesic Side Effects Report #5380862-4
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on June 26, 2007. Female patient, 40 years of age, weighting 210.0 lb, was diagnosed with pain and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site discolouration, homicide, overdose, . DURAGESIC dosage: unknown. During the same period patient was treated with OXYCONTIN. Patient died on 05/01/2004.

Listerine Side Effects Report #5795278-6
Consumer or non-health professional from UNITED STATES reported LISTERINE WHITENING QUICK DISSOLVING STRIPS problem on June 20, 2008. Female patient, 58 years of age, weighting 150.0 lb, was diagnosed with dental care and was treated with LISTERINE WHITENING QUICK DISSOLVING STRIPS. After drug was administered, patient experienced the following problems/side effects: application site burn, application site discolouration, . LISTERINE WHITENING QUICK DISSOLVING STRIPS dosage: unknown. Patient recovered.

Capzasin Side Effects Report #5736369-5
CAPZASIN NO MESS APPLICATOR problem was reported by a Consumer or non-health professional from UNITED STATES on May 09, 2008. Female patient, 37 years of age, weighting 130.0 lb, was diagnosed with arthralgia, myalgia and was treated with CAPZASIN NO MESS APPLICATOR. After drug was administered, patient experienced the following problems/side effects: application site burn, application site discolouration, application site dryness, application site exfoliation, application site pain, application site reaction, application site scar, application site vesicles, fear, . CAPZASIN NO MESS APPLICATOR dosage: unknown. During the same period patient was treated with CAPZASIN NO MESS APPLICATOR. Patient recovered.

Fragmin Side Effects Report #5715797-8
Consumer or non-health professional from BRAZIL reported FRAGMIN problem on Apr 07, 2008. Female patient, weighting 116.8 lb, was diagnosed with prophylaxis of abortion and was treated with FRAGMIN. After drug was administered, patient experienced the following problems/side effects: abortion, application site discolouration, . FRAGMIN dosage: unknown. Patient recovered.